Prograf is a Oral Granule, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Tacrolimus.
Product ID | 0469-1330_42ba828f-429f-4270-8758-e9d1ebb7855f |
NDC | 0469-1330 |
Product Type | Human Prescription Drug |
Proprietary Name | Prograf |
Generic Name | Tacrolimus |
Dosage Form | Granule, For Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2018-05-24 |
Marketing Category | NDA / NDA |
Application Number | NDA210115 |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | TACROLIMUS |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2018-05-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA210115 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-05-24 |
Ingredient | Strength |
---|---|
TACROLIMUS | 1 mg/1 |
SPL SET ID: | 7f667de1-9dfa-4bd6-8ba0-15ee2d78873b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0469-0607 | Prograf | Tacrolimus |
0469-0617 | Prograf | Tacrolimus |
0469-0657 | Prograf | Tacrolimus |
0469-1230 | Prograf | Prograf |
0469-1330 | Prograf | Prograf |
0469-3016 | Prograf | Prograf |
21695-170 | Prograf | Prograf |
43353-178 | Prograf | Prograf |
0093-3428 | Tacrolimus | tacrolimus |
0093-3429 | Tacrolimus | tacrolimus |
0168-0416 | Tacrolimus | tacrolimus |
0168-0417 | Tacrolimus | tacrolimus |
0378-2045 | Tacrolimus | Tacrolimus |
0378-2046 | Tacrolimus | Tacrolimus |
0378-2047 | Tacrolimus | Tacrolimus |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PROGRAF 74177939 1867420 Live/Registered |
ASTELLAS PHARMA INC. 1991-06-20 |